Cargando…

Drug holiday in patients with polycystic liver disease treated with somatostatin analogues

BACKGROUND: Somatostatin analogues (SAs) reduce liver volume and relief symptoms in polycystic liver disease (PLD). Its effect wears off after continuing therapy suggesting development of SA tolerance in patients on chronic therapy. We postulate that a drug holiday resensitizes the liver to its acut...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Aerts, René M. M., Kolkman, Marieke, Kievit, Wietske, Gevers, Tom J. G., Nevens, Frederik, Drenth, Joost P. H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172936/ https://www.ncbi.nlm.nih.gov/pubmed/30302127 http://dx.doi.org/10.1177/1756284818804784

Ejemplares similares

Estrogen‐Containing Oral Contraceptives Are Associated With Polycystic Liver Disease Severity in Premenopausal Patients
por: van Aerts, René M.M., et al.
Publicado: (2019)

Impact of liver volume on polycystic liver disease-related symptoms and quality of life
por: Neijenhuis, Myrte K, et al.
Publicado: (2017)

Rationale and design of the RESOLVE trial: lanreotide as a volume reducing treatment for polycystic livers in patients with autosomal dominant polycystic kidney disease
por: Gevers, Tom JG, et al.
Publicado: (2012)

The effect of disease severity markers on quality of life in autosomal dominant polycystic kidney disease: a systematic review, meta-analysis and meta-regression
por: Neijenhuis, Myrte K., et al.
Publicado: (2017)

Symptom relief and not cyst reduction determines treatment success in aspiration sclerotherapy of hepatic cysts
por: Neijenhuis, Myrte K., et al.
Publicado: (2018)

Treatment of Polycystic Liver Disease: Impact on Patient-reported Symptom Severity and Health-related Quality of Life
por: Duijzer, Renée, et al.
Publicado: (2022)

Abdominal wall hernia is a frequent complication of polycystic liver disease and associated with hepatomegaly
por: Barten, Thijs R. M., et al.
Publicado: (2022)

Glycemic profile in patients with acromegaly treated with somatostatin analogue
por: Valea, A, et al.
Publicado: (2015)

Long-acting somatostatin analogue treatments in autosomal dominant polycystic kidney disease and polycystic liver disease: a systematic review and meta-analysis
por: Griffiths, Joshua, et al.
Publicado: (2020)

The effects of somatostatin analogues on liver volume and quality of life in polycystic liver disease: a meta-analysis of randomized controlled trials
por: Garofalo, Carlo, et al.
Publicado: (2021)

Validation of a semi-automatic method to measure total liver volumes in polycystic liver disease on computed tomography — high speed and accuracy
por: Aapkes, Sophie E., et al.
Publicado: (2023)

Heterozygosity of ALG9 in Association with Autosomal Dominant Polycystic Liver Disease
por: Boerrigter, Melissa M., et al.
Publicado: (2023)

Polycystic liver disease: an overview of pathogenesis, clinical manifestations and management
por: Cnossen, Wybrich R, et al.
Publicado: (2014)

Loss of Heterozygosity Is Present in SEC63 Germline Carriers with Polycystic Liver Disease
por: Janssen, Manoe J., et al.
Publicado: (2012)

Management of portal hypertension and ascites in polycystic liver disease
por: Bernts, Lucas H. P., et al.
Publicado: (2019)

Bilateral Choroidal Metastases from Endobronchial Carcinoid Treated with Somatostatin Analogues
por: De Bruyn, Deborah, et al.
Publicado: (2016)

Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia
por: Haris, Basma, et al.
Publicado: (2020)

Combined treatment of somatostatin analogues with pegvisomant in acromegaly
por: Franck, S. E., et al.
Publicado: (2015)

Somatostatin Analogues for Receptor Targeted Photodynamic Therapy
por: Kaščáková, Slávka, et al.
Publicado: (2014)

Novel GANAB variants associated with polycystic liver disease
por: van de Laarschot, Liyanne F. M., et al.
Publicado: (2020)

Use of somatostatin analogues to treat chylothorax in a child with Generalised Lymphatic Dysplasia
por: Brodlie, Malcolm, et al.
Publicado: (2011)

Association between dopamine and somatostatin receptor expression and pharmacological response to somatostatin analogues in acromegaly
por: Venegas‐Moreno, Eva, et al.
Publicado: (2017)

Clinical response after laparoscopic fenestration of symptomatic hepatic cysts: a systematic review and meta-analysis
por: Bernts, Lucas H. P., et al.
Publicado: (2018)

Patient And Nurse Experience Of Using Somatostatin Analogues To Treat Gastroenteropancreatic Neuroendocrine Tumors: Results Of The Somatostatin Treatment Experience Trial (STREET)
por: Ström, Torbjörn, et al.
Publicado: (2019)

The potential role of somatostatin analogues in breast cancer treatment.
por: Pollak, M.
Publicado: (1997)

The holidays before the holidays
por: Staff Association
Publicado: (2019)

Holidays and Holiday-Makers
Publicado: (1904)

Prescription patterns of long-acting somatostatin analogues
por: Machado-Alba, Jorge Enrique, et al.
Publicado: (2017)

Patient reported outcome measure thresholds: The next step in the management of polycystic liver disease
por: Duijzer, Renée, et al.
Publicado: (2023)

Tamoxifen for the treatment of polycystic liver disease: A case report
por: Aapkes, Sophie E., et al.
Publicado: (2021)

Expression of Somatostatin Receptor 2 in Somatotropinoma Correlated with the Short-Term Efficacy of Somatostatin Analogues
por: Liu, Wenjuan, et al.
Publicado: (2017)

Novel α-1,3-Glucosyltransferase Variants and Their Broad Clinical Polycystic Liver Disease Spectrum
por: Boerrigter, Melissa M., et al.
Publicado: (2023)

Pulmonary neuroendocrine tumours and somatostatin receptor status: an assessment of unlicensed use of somatostatin analogues in the clinical practice
por: Kiesewetter, B., et al.
Publicado: (2022)

Everolimus and long acting octreotide as a volume reducing treatment of polycystic livers (ELATE): study protocol for a randomized controlled trial
por: Chrispijn, Melissa, et al.
Publicado: (2011)

A Rare Case of Thyrotropin Secreting Pituitary Macroadenoma Primarily Treated With Somatostatin Analogue
por: Elsheikh, Arwa Mahmoud, et al.
Publicado: (2021)

Somatostatin Receptor 2 Expression Profiles and Their Correlation with the Efficacy of Somatostatin Analogues in Gastrointestinal Neuroendocrine Tumors
por: Watanabe, Hirofumi, et al.
Publicado: (2022)

Estrogens in polycystic liver disease: A target for future therapies?
por: Aapkes, Sophie E., et al.
Publicado: (2021)

Feasibility of Imaging Esophageal Cancer with Labeled Somatostatin Analogue
por: Herlin, Gunnar, et al.
Publicado: (2011)

Somatostatin analogues for refractory diarrhoea in familial amyloid polyneuropathy
por: Collins, Michael, et al.
Publicado: (2018)

Medical Treatment with Somatostatin Analogues in Acromegaly: Position Statement
por: Chin, Sang Ouk, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_7oi0nnioo03j8b0onugimm5bu8